相关实验视频
Updated: Feb 6, 2026

08:51
A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
14.8K
大动脉病理的内血管治疗
Deutsches Arzteblatt international
|February 4, 2026
概括
内血管修复为大动脉病理提供了一种最小侵入性的替代方案,特别是在高风险患者中. 虽然有效,但谨慎的患者选择和假肢选择对于这个不断发展的领域的最佳结果至关重要.
科学领域:
- 心血管外科心血管外科
- 血管外科 血管外科
- 干预性放射学 干预性放射学
背景情况:
- 内血管治疗是对大动脉门病理的既定选择,作为选择患者的开放手术的替代方案.
- 胸前大动脉动脉瘤影响大约0.16%的人口.
研究的目的:
- 审查对大动脉门疾病的内血管治疗选择.
主要方法:
- 这项研究是一篇叙事性综述,介绍了大动脉病理的内血管治疗策略.
- 它讨论了内血管修复的先决条件,包括适当的近端和远端着陆区域.
主要成果:
- 内血管大动脉门手术的技术成功率很高 (例如,分支TEVAR: 96.3%,窗口TEVAR: 95.7%).
- 权重平均30天死亡率为6.3%,中风率为9.4%. 恩多莱克的发病率各不相同 (2.6%37.6%,平均为19.6%).
- 这种微创手术方法是专门中心高风险患者的开放手术的可行替代方案.
结论:
- 目前的证据主要来自回顾性研究; 缺乏比较内血管修复与开放手术的随机对照试验.
- 大动脉假肢的进步允许更个性化的治疗.
- 跨学科团队必须仔细考虑个别患者的风险概况和假肢选择.
相关概念视频
The Arch of Aorta
1.8K
The coronary arteries, originating from the ascending aorta, bifurcate from two sinuses located within the ascending aorta. Positioned just above the aortic semilunar valve, these sinuses house essential aortic baroreceptors and chemoreceptors, crucial for maintaining cardiac function. The left coronary artery and the right coronary artery branch off from the left posterior and anterior aortic sinuses, respectively.
Encircling the heart, the coronary arteries form a ring-like structure before...
Encircling the heart, the coronary arteries form a ring-like structure before...
1.8K
Aortic Regurgitation I: Introduction
641
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
641
Aortic Regurgitation III: Medical Management
456
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
456
Aortic Regurgitation IV: Nursing Management
324
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
324
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K

